EQS-CMS

    121 Aufrufe 121 0 Kommentare 0 Kommentare

    Fresenius Medical Care AG : Release of a capital market information

    Für Sie zusammengefasst
    • Fresenius Medical Care AG announces share buyback details.
    • 3,381 shares bought back from Oct 6 to Oct 10, 2025.
    • Total of 3,576,254 shares acquired in the buyback.

    EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014
    Fresenius Medical Care AG : Release of a capital market information

    13.10.2025 / 15:59 CET/CEST
    Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.
    The issuer is solely responsible for the content of this announcement.


    Fresenius Medical Care AG: Share buyback

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Fresenius Medical Care AG!
    Long
    37,44€
    Basispreis
    0,31
    Ask
    × 12,67
    Hebel
    Zum Produkt
    Blatt
    Short
    43,57€
    Basispreis
    0,34
    Ask
    × 12,30
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

     

    Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

    Share buyback – Interim Report

    In the period from October 6, 2025 to October 10, 2025 (each inclusive), 3,381 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

    Shares were bought back as follows:

    Date Acquired shares (number) Weighted average price (in EUR) Transaction volume
    (in EUR)
    Trading venue
    6 October 2025 3,381 45.4221 153,572.09 XETA

     

    A total of 3,576,254 shares have been acquired within the framework of this share buyback.

    The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

    Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.



    13.10.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: Fresenius Medical Care AG
    Else-Kröner-Straße 1
    61352 Bad Homburg
    Germany
    Internet: www.freseniusmedicalcare.com

     
    End of News EQS News Service

    2212148  13.10.2025 CET/CEST





    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-CMS Fresenius Medical Care AG : Release of a capital market information EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital market information 13.10.2025 / 15:59 CET/CEST …